comparemela.com

Latest Breaking News On - Serum institute covaxin - Page 1 : comparemela.com

India Coronavirus Cases: 3 11 Lakh New Covid Cases In India, 4,077 Deaths; 2 46 Crore Total Cases

India Covid Cases: 4,077 people died in the last 24 hours in the country. New Delhi: India logged 3.11 lakh fresh Covid cases in the last 24 hours, taking the overall caseload to 2.46 crore. The country recorded 4,077 deaths in the last 24 hours, taking the total number of deaths to 2.7 lakh. Here is your ten-point cheat sheet on this big story: India has been recording more than 1 lakh infections every day since April 5. While the country has seen a drop in Covid cases lately, nearly 40 lakh cases have been logged in the last 10 days alone. Prime Minister Narendra Modi on Saturday held a high-level meeting to review India s Covid situation. India s testing capacity has increased significantly from around 50 lakh tests per week in early March to around 1.3 crore tests per week now, he was told.

India Coronavirus Dispatch: Vaccine candidates in development in India

Vaccine candidates currently in development in India The following candidates are in various stages of trials to assess safety and efficacy in India, according to a report in the BBC. This is apart from Serum Institute s Covaxin and Bharat Biotech s Covishield, which have already received emergency approval. 1) ZyCov-Di, being developed by Ahmedabad-based Zydus-Cadila 2) In partnership with US-based Dynavax and Baylor College of Medicine, Hyderabad-based Biological E, the first Indian private vaccine company, is developing a vaccine 3) In partnership with Seattle-based HDT Biotech Company, HGCO19, India s first mRNA vaccine developed by Pune-based Genova, uses bits of genetic code to induce an immune response

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.